Media Pack
News

Current Edition

JCS Volume 15 Issue 3
 
Regional News

FDA endorses Novartis’ ‘pipeline in a pill,’ granting first nod for potential blockbuster Fabhalta

Novartis has gained the first of what it hopes are several FDA approvals for its factor B inhibitor iptacopan, dubbed two months ago “a pipeline in pill,” by analyst...
7 December 2023 Regional News
Continue Reading →
Regional News

SABCS: Handing Novartis a win, Lilly’s Verzenio barely misses overall survival goal in first-line breast cancer

Novartis’ Kisqali is getting a leg up in the CDK4/6 breast cancer realm as another rival failed to significantly extend patients’ lives in a pivotal trial. A phas...
7 December 2023 Regional News
Continue Reading →
Regional News

Daiichi Sankyo scores $182M from Novartis settlement in long-running patent case

After years of back and forth with Daiichi Sankyo over cancer drug patent claims, Novartis has thrown in the towel with a $182 million settlement. The case stems ...
7 December 2023 Regional News
Continue Reading →
Regional News

Salix, seeking to tackle stigma, co-creates awareness day for opioid-induced constipation

Salix Pharmaceuticals is putting a new date in the disease awareness calendar. Working with two nonprofits, the drugmaker has declared Dec. 5 Opioid-Induced Constipa...
7 December 2023 Regional News
Continue Reading →
Regional News

To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic

Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing p...
23 November 2023 Regional News
Continue Reading →
Regional News

AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players

Looking to protect its lucrative immunology drug Rinvoq, AbbVie is suing a clutch of generic drug makers that are attempting to market copycat versions of the blockb...
23 November 2023 Regional News
Continue Reading →
Regional News

Bayer’s trial flop, courtroom setback could restrict CEO’s options amid strategic review: analyst

After suffering setbacks in the clinic and in court over the last week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group o...
23 November 2023 Regional News
Continue Reading →
Regional News

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs 

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs  Pre-configured, scalable trial management system enables quick...
22 November 2023 Regional News | Uncategorised
Continue Reading →
Regional News

CorMedix gains hard-fought approval for combo drug that reduces risk of catheter infection during dialysis

CorMedix went through a lot to secure its FDA approval for DefenCath. There was a reorganization, a CEO change, an exit from Europe, two complete response letters an...
16 November 2023 Regional News
Continue Reading →
Regional News

Catalent aims to push through COVID slog with gene therapy, GLP-1 hype

Like many other COVID-19 players, CDMO Catalent has been feeling the heat of plunging COVID product demand. But with a manufacturing push from partner Sarepta Therap...
16 November 2023 Regional News
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte